Published in Managed Care Weekly Digest, September 6th, 2004
With this capital, the company is accelerating the commercialization of its new IT-based portfolio of biospecimen management solutions for both academic medical centers and pharmaceutical/biotechnology companies.
Donald B. Hawthorne, Ardais' recently-appointed CEO, explained: "Since its inception, Ardais has successfully set the gold standard...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Weekly Digest